Effect of thiazolidinedione therapy on the risk of uric acid stones.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31010476.
- Also identified by DOI 10.1016/j.kint.2019.02.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The most important variable leading to uric acid stones is low urine pH. Major causal conditions associated with low urine pH are metabolic syndrome and diabetes. In the study by Maalouf et al., treatment of uric acid stone formers with pioglitazone led to small but significant increases in urine pH. Pioglitazone will not supplant alkali administration to prevent uric acid stones, but the study helps confirm that insulin resistance is an important cause of low urine pH that causes uric acid stones.
Medical subject headings
- Kidney Calculi
- Thiazolidinediones